Extended half‐life upon binding of destabilized intrabodies allows specific detection of antigen in mammalian cells

The ectopic expression of antibody fragments inside mammalian cells (intrabodies) is a challenging approach for probing and modulating target activities. We previously described the shuttling activity of intracellularly expressed Escherichia coliβ‐galactosidase conferred by the single‐chain Fv (scFv) fragment 13R4 equipped with nuclear import/export signals. Here, by appending to scFvs the proteolytic PEST signal sequence (a protein region rich in proline, glutamic acid, serine and threonine) of mouse ornithine decarboxylase, we tested whether short‐lived or destabilized intrabodies could affect the steady‐state level of target by redirecting it to the proteasomes. In the absence of antigen, the half‐life of the modified scFv 13R4, relative to untagged molecules, was considerably reduced in vivo. However, after coexpression with either cytoplasmic or nuclear antigen, the destabilized 13R4 fragments were readily maintained in the cell and strictly colocalized with β‐galactosidase. Analysis of destabilized site‐directed mutants, that were as soluble as 13R4 in the intracellular context, demonstrated that binding to antigen was essential for survival under these conditions. This unique property allowed specific detection of β‐galactosidase, even when expressed at low level in stably transformed cells, and permitted isolation by flow cytometry from a transfected cell mixture of those living cells specifically labeled with bound intrabody. Altogether, we show that PEST‐tagged intrabodies of sufficient affinity and solubility are powerful tools for imaging the presence and likely the dynamics of protein antigens that are resistant to proteasomal degradation in animal cells.

[1]  B. Deroo,et al.  Proteasome Inhibitors Reduce Luciferase and β-Galactosidase Activity in Tissue Culture Cells* , 2002, The Journal of Biological Chemistry.

[2]  T. Rabbitts,et al.  De novo production of diverse intracellular antibody libraries. , 2003, Nucleic acids research.

[3]  G. M. Leclerc,et al.  Development of a destabilized firefly luciferase enzyme for measurement of gene expression. , 2000, BioTechniques.

[4]  R. Deshaies,et al.  A Proteasome Howdunit The Case of the Missing Signal , 2000, Cell.

[5]  E. Weiss,et al.  Production of fluorescent single-chain antibody fragments in Escherichia coli. , 2000, Protein expression and purification.

[6]  M. Sierks,et al.  A human single-chain Fv intrabody blocks aberrant cellular effects of overexpressed α-synuclein , 2004 .

[7]  A. Verkman Diffusion in cells measured by fluorescence recovery after photobleaching. , 2003, Methods in enzymology.

[8]  A. Schots,et al.  Formation of Disulfide Bridges by a Single-chain Fv Antibody in the Reducing Ectopic Environment of the Plant Cytosol* , 2002, The Journal of Biological Chemistry.

[9]  David W. Colby,et al.  Potent inhibition of huntingtin aggregation and cytotoxicity by a disulfide bond-free single-domain intracellular antibody. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[10]  A. Varshavsky,et al.  In vivo half-life of a protein is a function of its amino-terminal residue. , 1986, Science.

[11]  P. Martineau,et al.  Nucleocytoplasmic shuttling of antigen in mammalian cells conferred by a soluble versus insoluble single-chain antibody fragment equipped with import/export signals. , 2003, Experimental cell research.

[12]  T. Terwilliger,et al.  Rapid protein-folding assay using green fluorescent protein , 1999, Nature Biotechnology.

[13]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[14]  C. Tyler-Smith,et al.  Attenuation of green fluorescent protein half-life in mammalian cells. , 1999, Protein engineering.

[15]  A. Rajpal,et al.  Intracellular Stability of Anti-caspase-3 Intrabodies Determines Efficacy in Retargeting the Antigen* , 2001, The Journal of Biological Chemistry.

[16]  G. V. Shpakovski,et al.  A human RNA polymerase II subunit is encoded by a recently generated multigene family , 2001, BMC Molecular Biology.

[17]  E. Weiss,et al.  Preferential nuclear localization of the human papillomavirus type 16 E6 oncoprotein in cervical carcinoma cells. , 2003, The Journal of general virology.

[18]  D. Danley,et al.  Extended half-life and elevated steady-state level of a single-chain Fv intrabody are critical for specific intracellular retargeting of its antigen, caspase-7. , 1999, Journal of immunological methods.

[19]  A. Cattaneo,et al.  Intracellular antibodies for proteomics☆ , 2004, Journal of Immunological Methods.

[20]  M. Stocks Intrabodies: production and promise. , 2004, Drug discovery today.

[21]  D. Wolf,et al.  Proteasomes: destruction as a programme. , 1996, Trends in biochemical sciences.

[22]  Aaron Ciechanover,et al.  The ubiquitin–proteasome pathway: on protein death and cell life , 1998, The EMBO journal.

[23]  S. Matsufuji,et al.  Degradation of ornithine decarboxylase by the 26S proteasome. , 2000, Biochemical and biophysical research communications.

[24]  M. Sierks,et al.  A human single-chain Fv intrabody blocks aberrant cellular effects of overexpressed alpha-synuclein. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[25]  B. Goud,et al.  Recombinant Antibodies Against Subcellular Fractions Used to Track Endogenous Golgi Protein Dynamics in Vivo , 2003, Traffic.

[26]  T. Rabbitts,et al.  Intracellular antibody-caspase-mediated cell killing: an approach for application in cancer therapy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Mingsheng Zhang,et al.  Determinants of proteasome recognition of ornithine decarboxylase, a ubiquitin‐independent substrate , 2003, The EMBO journal.

[28]  D. Duché,et al.  Intracellular Immunization of Prokaryotic Cells against a Bacteriotoxin , 1998, Journal of bacteriology.

[29]  A. Goldberg,et al.  Proteasome inhibitors: valuable new tools for cell biologists. , 1998, Trends in cell biology.

[30]  S. Rogers,et al.  PEST sequences and regulation by proteolysis. , 1996, Trends in biochemical sciences.

[31]  R. Kontermann Intrabodies as therapeutic agents. , 2004, Methods.

[32]  J. Neefjes,et al.  From fixed to FRAP: measuring protein mobility and activity in living cells , 2001, Nature Cell Biology.

[33]  Gösta Winberg,et al.  NotI passporting to identify species composition of complex microbial systems. , 2003, Nucleic acids research.

[34]  T. Rabbitts,et al.  Intracellular antibodies and challenges facing their use as therapeutic agents. , 2003, Trends in molecular medicine.

[35]  P. Martineau,et al.  Expression of an antibody fragment at high levels in the bacterial cytoplasm. , 1998, Journal of molecular biology.

[36]  R. Kopito,et al.  Impairment of the ubiquitin-proteasome system by protein aggregation. , 2001, Science.

[37]  E. Kabat,et al.  Sequences of proteins of immunological interest , 1991 .

[38]  S. Kain,et al.  Generation of Destabilized Green Fluorescent Protein as a Transcription Reporter* , 1998, The Journal of Biological Chemistry.

[39]  R. Chiaraluce,et al.  A semi-synthetic repertoire of intrinsically stable antibody fragments derived from a single-framework scaffold. , 2001, Journal of molecular biology.